HeMemics Biotechnologies, Inc, a Rockville-based TEDCO portfolio company, received a $2.5 million investment from AMVI Partners
Source: External source
Hememics Biotechnologies Inc. plans to use the investment from AMVI Partners to begin clinical research for FDA submission for its flagship biotech product, a point-of-care panel to test for sexually transmitted diseases
Posted December 17, 2019
About TEDCO
TEDCO, the Maryland Technology Development Corporation, enhances economic empowerment growth through the fostering of an inclusive entrepreneurial innovation ecosystem. TEDCO identifies, invests in, and helps grow technology and life science-based companies in Maryland. Learn more at www.tedcomd.com.
Media Contacts
Tammi Thomas, President, TEDCO, tthomas@tedcomd.com
Rachael Kalinyak, Associate Director, Marketing & Communications, TEDCO, rkalinyak@tedcomd.com